We are live on ! Find out more
LUCD icon

Lucid Diagnostics
LUCD

19 hedge funds and large institutions have $2.49M invested in Lucid Diagnostics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0.82% less ownership

Funds ownership: 4.9% → 4.08% (-0.82%)

5% less capital invested

Capital invested by funds: $2.6M → $2.49M (-$118K)

17% less funds holding

Funds holding: 23 → 19 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LM
Luminus Management
Texas
+$42K
2
VF
Virtu Financial
New York
+$21.5K
3
Verition Fund Management
Verition Fund Management
Connecticut
+$19.8K
4
Osaic Holdings
Osaic Holdings
Arizona
+$1.39K
5
BlackRock
BlackRock
New York
+$856

Top Sellers

Rank Fund Capital Flow
1
KCM
Kornitzer Capital Management
Kansas
-$181K
2
LCS
Levin Capital Strategies
New York
-$50K
3
NCM
Nantahala Capital Management
Connecticut
-$24.7K
4
Millennium Management
Millennium Management
New York
-$24K
5
ACP
Arcus Capital Partners
Georgia
-$4.22K

LUCD Hedge Fund Activity: Q1 2023 in Review

19 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2023, worth a combined $2.49M — down 4.5% from $2.6M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of LUCD and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 6 added.

The largest buyer was Luminus Management, adding an estimated $42K. The largest seller was Kornitzer Capital Management, exiting entirely with an estimated $181K sold.

  • 19 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2023, down from 23 in Q4 2022.
  • Funds reported $2.49M of Lucid Diagnostics stock for Q1 2023, down 4.5% quarter-over-quarter.
  • 1 fund opened new Lucid Diagnostics positions in Q1 2023 and 5 closed out, a net change of -4 holders.
  • The largest Lucid Diagnostics buyer in Q1 2023 was Luminus Management, an estimated $42K added.
  • The largest Lucid Diagnostics seller in Q1 2023 was Kornitzer Capital Management, an estimated $181K sold.

Based on aggregated 13F filings for Q1 2023.